Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 29, 2021

SELL
$9.85 - $17.69 $189,218 - $339,824
-19,210 Closed
0 $0
Q4 2020

Jan 14, 2021

BUY
$14.15 - $17.19 $81,928 - $99,530
5,790 Added 43.14%
19,210 $297,000
Q3 2020

Oct 15, 2020

BUY
$14.14 - $19.71 $5,231 - $7,292
370 Added 2.84%
13,420 $196,000
Q2 2020

Jul 20, 2020

BUY
$16.6 - $25.25 $216,630 - $329,512
13,050 New
13,050 $247,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $336M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Vigilare Wealth Management Portfolio

Follow Vigilare Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Vigilare Wealth Management with notifications on news.